Presented by

The official calendar of Deep Tech Week. Website: https://deep-tech-week.com/ Official Discord: https://discord.gg/pnmn9XfR8C Organizer: https://x.com/Andercot

Hosted By

275 Went

Ligandal Biotech Summit

Name: Ligandal Biotech Summit
Start: 2025-06-26T17:00:00.000-07:00
End: 2025-06-26T21:00:00.000-07:00
Location: 1 Beach St

Deep Tech Week

1 Beach St

San Francisco, California

Past Event

Please click on the button below to join the waitlist. You will be notified if additional spots become available.

You will be asked to verify token ownership with your wallet.

About Event

Join us for an exclusive evening at Deep Tech Week’s Biotech Summit, where world-leading scientists, engineers, and founders are redefining the frontiers of medicine and programmable biology.

This summit brings together pioneers in targeted therapeutic delivery, gene therapy platforms, protein and genomic language and deep learning models, AI, diagnostics & theranostics, advanced transcriptomic analytics, and next-generation automation. Explore the breakthroughs enabling truly personalized, predictive, and curative care across rare disease, oncology, immune and metabolic disorders, and beyond.

Highlights include:

Fireside chats with industry and scientific leaders on the future of personalized and precision medicine, gene therapy, and platform commercialization
Keynote from Stanford’s James Zou, PhD: “AI Scientist Agents to Accelerate Drug Discovery and Development”
Lightning talks from experts in protein design AI, microfluidics, lab automation, digital diagnostics, surgical AI, and immunometabolism drug discovery
Networking with top founders, investors, academics, and R&D decision-makers

If you’re building, investing in, or partnering across biotech, digital health, or enabling platform tech, this summit is your chance to engage with the minds shaping the next decade of curative medicine. If you're an investor, bring your checkbook, and learn about the hottest startups in the space.

For questions, contact dre@ligandal.com (Follow on X)

AGENDA

5:30 PM — Opening Remarks

Welcome and Summit Overview

Matt O’Brien, JD (Pillsbury Winthrop Shaw Pittman LLP)

Andre Watson (Ligandal)

5:40 PM — Enabling the Future of Personalized, Precision, and Predictive Medicine – How Delivery is the Final Frontier of Curative Medicine

Andre Watson (CEO & Founder, Ligandal)

5:50 PM — Fireside Chat: Platforms & Personalized Medicine – Barriers & Opportunities

Nicole Fay, PhD (Nutcracker Therapeutics) and Andre Watson (Ligandal)

6:05 PM — Fireside Chat: Personalized Medicine, the Future of Gene Therapy, and Market Evolution

Emily Capra, PhD (McKinsey & Company) and Andre Watson (Ligandal)

6:25 PM — Break

6:30 PM — Keynote: AI Scientist Agents to Accelerate Drug Discovery and Development

James Zou, PhD (Stanford University)

Lightning Talks

7:00 PM — AlphaFold2 Was Just the Beginning—Tackling Protein Dynamics and Function with AI

Gina El Nesr, ABD (Stanford Biophysics)

7:15 PM — Unleashing 1,000,000x Lab Productivity with AI-Powered Automation

Ainur Nygmet (Faberge Labs)

7:30 PM — See (exactly) what you treat: Designing new halogen radio-theranostics for the treatment of solid tumors

Louis Metzger (dGenThera)

7:45 PM - AI for Automating Surgical Outcomes in Orthopaedics and Beyond

Adrian Killan (Mango Medical)

8:00 PM — Inapill: Immunometabolism-Targeted Small Molecules for Autoimmunity

Greg Timblin, PhD (Inapill)

8:15 PM — Beyond pills and infusions: Building hardware that treats cancer

Vivek Sharma, MS, ME, MBA (Asha Medical)

8:30 PM — The present, past, and future of blood testing

Michael Dubrovsky (SiPhox)

8:45 PM — Closing Remarks

Call-to-Action and Networking - Invitation to VIP Afterparty

Andre Watson (Ligandal)

SPEAKER BIOGRAPHIES

James Zou, PhD

Associate Professor, Biomedical Data Science, CS and EE, Stanford University

AI for science; Faculty director of Stanford AI for Health; Overton Prize, Sloan Fellowship, 2x Chan-Zuckerberg Investigator.

Developer of robust machine-learning frameworks for biotech applications; specializes in reliable AI models for protein sequence–function prediction.

Andre Watson

CEO & Founder, Ligandal

Inventor of 88 patents, Forbes 30 Under 30 (Healthcare 2021); biomedical engineer and nanoscientist pioneering peptide-based targeted delivery for gene and drug therapies including CRISPR and mRNA.

Nicole Fay, PhD

Senior Director, Alliance Management, Nutcracker Therapeutics

Molecular biologist focused on drug discovery and design for novel RNA therapeutics, making medicine more accessible and individualized.

Gina El Nesr, ABD

PhD Candidate, Biophysics, Stanford University

Develops deep-learning methods for de novo protein design, enzymatic function, allostery, and modeling protein dynamics for new-to-nature mechanisms.

Louis Metzger, PhD

Co-Founder & CEO, dGenThera

Louis Metzger is Co-founder and CEO of dGenThera, a radiopharmaceutical startup that leverages novel halogen chemistry to design theranostics for the treatment of solid tumors. He spent several years at Novartis Pharma and subsequently held leadership roles in synthetic biology and gene therapy startups. He is passionate about contributing to healthspan extension, particularly for cancer survivors, by developing targeted radiotherapeutics that can induce long-term remission while minimizing late-onset damage to healthy tissues.

Emily Capra, PhD

Partner & Head of New Modalities Service Line, McKinsey & Company

Leads life-science R&D strategy for novel modalities, guiding pharma and biotech on commercializing next-generation therapies. AB Princeton, PhD MIT, Postdoc Caltech.

Ann (Ainur) Nygmet

Founder, Faberge Labs

Engineer turned founder dedicated to revolutionizing lab automation with intelligent AI assistance. Ainur has successfully automated over 50 complex methods in cancer drug discovery pipelines and is passionate about freeing researchers from repetitive tasks and accelerating scientific breakthroughs. Her expertise lies in bridging the gap between biology and robotics to drive innovation in the lab.

Michael Dubrovsky

Co-Founder & CPO, SiPhox Health

Materials chemist and entrepreneur building a chip-based at-home blood-testing device; former developer of photonic computing for cryptography.

Adrian Killan

CEO, Mango Medical

Building AI platforms that automate surgical outcome predictions for orthopaedics and beyond, merging deep learning with personalized surgical interventions.

Greg Timblin, PhD

CEO, Inapill

Developing first-in-class small molecule therapeutics targeting immunometabolism for improved treatment of inflammatory and autoimmune diseases; based at the Bakar BioEnginuity Hub, UC Berkeley.